Article Sidebar
Views PDF: 315
Remarking the first step results of the role of f-18 fdg pet/ct in determining the positive position in the unknow cancer in the cancer national Hospital
Main Article Content
Abstract
SUMMARY
Carcinoma of unknown primary tumors (CUP) is present in 2% of all patients with malignant neoplasms. However, only 20% - 73% of primary sites are identified before the patients die. Currently, F-18 FDG PET/CT is widely used for the diagnosis of CUP. The objective of this study was to evaluate the role of F-18 FDG PET / CT in these patients.
Results: 30 patients with unclear cancers were treated with F-18 FDG PET / CT, the mean age of patients was 53.6 ± 9.7. There were 18/30 patients
(60%) who were diagnosed with cancer. PET / CT (compared with pathology),the rest is false 12/30 BN (40%). Localized nodal metastases is an area of the neck. The most common pathological anomalies were squamous cell carcinoma
(56.7%), adenocarcinoma (16.7%) and noncancerous cancers (26.7%).
Conclusion: F-18 FDG PET / CT is a useful method for detecting primary malignant sites in patients with primary tumors.
Article Details
References
1. AglundM, Kjems E. Statistics on cancer of unknown primary (in Danish) [The Danish Cancer Society]. January
12, 2017. Available at: https://www.cancer.dk/hjaelp viden/kraeftformer/metastaser-spredning/ukendt primaertumor/ statistik-ukendt-primaer-tumor/. Accessed February 27, 2017.
2. Le Chevalier T, Cvitkovic E, Caille P, Harvey J, Contesso G, Spielmann M, Rouesse J: Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 1988, 148:2035-2039.
3. Raber MN, Faintuch J, Abbruzzese JL, Sumrall C, Frost P: Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin. AnnOncol 1991, 2:519-520.
4. Haas I, Hoffmann TK, Engers R, Ganzer U: Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol 2002,259:325-333.
5. Kwee TC, Basu S, Cheng G, Alavi A: FDG PET/CT in carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2010, 37:635-644.
6. Kwee TC, Kwee RM: Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol 2009, 19:731-744.
7. Gutzeit A, Antoch G, Kuhl H, Egelhof T, Fischer M, Hauth E, Goehde S, Bockisch A, Debatin J, Freudenberg L: Unknown primary tumors: detection with dual-modality PET/CT–initial experience. Radiology 2005, 234:227-234.
8. American Cancer Society. Available at: https://www.cancer.org/cancer/cancer-unknown primary/about/keystatistics. html. Accessed February 27, 2017, in press.
9. Sève P, Billotey C, Broussolle C,Dumontet C, Mackey JR (2007) The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography indisseminated carcinoma of unknown primary site. Cancer 109:292–299.
10. Delgado-Bolton RC, Fernández-PérezC, González-Maté A, Carreras JL(2003) Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med 44:1301–1314.
11. Møller AK, Loft A, Berthelsen AK, et al. 18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review. Oncologist 2011;16:445–51.
12. Burglin S.A, Søren Hess, et al. 18F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: a systematic review and meta-analysis. Medicine (2017) 96:16(e6713).
13. Lê Ngọc Hà, Mai Hồng Sơn, F-18 FDG PET/CT trong phát hiện vị trí tổn thương ở bệnh nhân ung thư chưa rõ nguyên phát (2017). Tạp chí y học thực hành bệnh viện TƯQĐ 108, tháng 12/2017.